NuGen Medical Devices Inc. (NGMDF)
| Market Cap | 4.10M -69.4% |
| Revenue (ttm) | 423.17K -22.7% |
| Net Income | -1.52M |
| EPS | -0.01 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,000 |
| Average Volume | 22,854 |
| Open | 0.0181 |
| Previous Close | n/a |
| Day's Range | 0.0181 - 0.0181 |
| 52-Week Range | 0.0001 - 0.0680 |
| Beta | 1.65 |
| RSI | 39.88 |
| Earnings Date | Apr 30, 2026 |
About NuGen Medical Devices
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered i... [Read more]
Financial Performance
In 2024, NuGen Medical Devices's revenue was 1.01 million, an increase of 204.73% compared to the previous year's 331,403. Losses were -5.23 million, -44.18% less than in 2023.
Financial numbers in CAD Financial StatementsNews
NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology
Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering a Re...
NuGen Medical Devices Inc. Provides Update on Health Canada License
Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse of i...
NuGen Medical Devices Inc. Announces CFO Transition
Toronto, Ontario--(Newsfile Corp. - January 30, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, announces tha...
NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress
Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is providing ...
NuGen Medical Devices Announces NHS Drug Tariff Approval for EziAutoJector(R) Product Line in the UK
Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased ...
NuGen Capital Management to Invest $100MM in Solar Energy Projects
PROVIDENCE, R.I.--(BUSINESS WIRE)--NuGen Capital Management, LLC (NuGen), a national leader in energy development and capital solutions, today announced it is making an additional investment of $100 m...
Nugen Raises Pre-Seed to Pioneer Reliable AI for Businesses
MUMBAI, India & SAN FRANCISCO--(BUSINESS WIRE)-- #AI--Nugen announced pre-seed round to advance its mission of making AI reliable for businesses.
NuGen Medical Devices Announces New Needle-Free Injection System Featuring Internal Cartridge Technology
Toronto, Ontario--(Newsfile Corp. - August 21, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to ...
InsuJet Distribution Expands Across France
NuGen Medical Devices Launches French InsuJet(TM) e-Commerce Platform, Delivering Needle-Free Insulin with On-Demand Clinical Support Toronto, Ontario--(Newsfile Corp. - July 7, 2025) - NuGen Medical ...
NuGen Announces Release of 2024 Annual Financial Results
Toronto, Ontario--(Newsfile Corp. - April 30, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices for the subcutaneous administration...
InsuJet Distribution Expands Across Canada
Toronto, Ontario--(Newsfile Corp. - April 24, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutane...
NuGen Announces the Appointment of Liang Lin as Chief Executive Officer
Toronto, Ontario--(Newsfile Corp. - January 14, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcuta...
NuGen Announces Canada-Wide Launch of InsuJet
3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across Canada Toronto, Ontario--(Newsfile Corp. - November 22, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a le...
NuGen Announces Results of Special Meeting and Appointment of New Directors
Toronto, Ontario--(Newsfile Corp. - November 14, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcut...
NuGen Announces Strategic Partnership with EziAutoJector Limited
5,000 InsuJet devices to be delivered to the UK Toronto, Ontario--(Newsfile Corp. - October 25, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle...
NuGen Announces Closing of Private Placement of $10 million Secured Convertible Debentures
Toronto, Ontario--(Newsfile Corp. - September 20, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcu...
NuGen Announces Release of Financial Results for Q2 2024 & Update on Proposed Private Placement
Toronto, Ontario--(Newsfile Corp. - August 29, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices for the subcutaneous administration...
NuGen Announces Voting Results of Annual and Special Meeting
Toronto, Ontario--(Newsfile Corp. - August 21, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutan...
NuGen Announces Revised Terms of Proposed Private Placement of up to $10 Million Secured Convertible Debentures
Toronto, Ontario--(Newsfile Corp. - August 15, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutan...
NuGen Receives Order for Repeat Demand in Mexico
Toronto, Ontario--(Newsfile Corp. - July 19, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneo...
NuGen Announces Proposed Private Placement of up to $10 million Secured Convertible Debentures
Toronto, Ontario--(Newsfile Corp. - July 10, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneo...
NuGen Develops Pharmacist Training Packages for the Canadian Retail Pharmacy Market
Toronto, Ontario--(Newsfile Corp. - July 9, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneou...
NuGen Announces Completion of InsuJet(TM) Training with Sol-Millennium(TM) Brazil
Toronto, Ontario--(Newsfile Corp. - July 1, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneou...
NuGen Announces Repeat Order for Growing InsuJet(TM) Demand in Yemen
Toronto, Ontario--(Newsfile Corp. - June 28, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneo...
NuGen Announces Initial Purchase Order from Sol-Millennium(TM) for Pharmacy Launches in the Canadian and European Markets
Toronto, Ontario--(Newsfile Corp. - June 21, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices for the subcutaneous administration o...